Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines

Background: Lung-transplant (LT) recipients are at high risk for COVID-19 due to immunosuppression and respiratory tropism of SARS-CoV-2. The information on the effect of COVID-19 mRNA vaccines to elicit immunogenic responses after a two-dose (2D) regimen in LT recipients is sparse. Thus, we assesse...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vaccines (Basel)
Egile Nagusiak: Narasimhan, Madhusudhanan, Mahimainathan, Lenin, Clark, Andrew E, Usmani, Amena, Cao, Jing, Araj, Ellen, Torres, Fernando, Sarode, Ravi, Kaza, Vaidehi, Lacelle, Chantale, Muthukumar, Alagarraju
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Communication
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310345/
https://ncbi.nlm.nih.gov/pubmed/34208884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070708
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak